Provided by Tiger Fintech (Singapore) Pte. Ltd.

Natera

140.94
-11.0300-7.26%
Volume:858.40K
Turnover:122.13M
Market Cap:19.05B
PE:-92.31
High:146.76
Open:146.24
Low:137.81
Close:151.97
Loading ...

Market Sentiment Around Loss-Making Natera, Inc. (NASDAQ:NTRA)

Simply Wall St.
·
24 Jan

BUZZ-Barclays starts coverage on Natera with 'outperform' rating

Reuters
·
24 Jan

Natera Initiated at Overweight by Barclays

Dow Jones
·
24 Jan

Barclays Initiates Natera at Overweight

MT Newswires Live
·
23 Jan

Natera initiated with an Overweight at Barclays

TIPRANKS
·
23 Jan

Natera to Present New Data at the 2025 ASCO GI Symposium

Business Wire
·
22 Jan

Druckenmiller says CEOs are excited due to Trump. Why he's cautious on the stock market.

Dow Jones
·
21 Jan

Natera Is Maintained at Buy by Guggenheim

Dow Jones
·
17 Jan

Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year

Business Wire
·
17 Jan

Bernstein Keeps Their Buy Rating on Natera (NTRA)

TIPRANKS
·
16 Jan

Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection

Business Wire
·
15 Jan

Natera Says Preliminary Q4 Revenue Up 52%

MT Newswires Live
·
13 Jan

Natera reports preliminary Q4 revenue $472M, consensus $409.91M

TIPRANKS
·
13 Jan

BRIEF-Natera Inc Says Co Expects Total Revenues Of Approximately $1.7 Bln In Full Year 2024

Reuters
·
13 Jan

Natera Inc - Total Revenues of Approx $472 Mln in Q4 of 2024

THOMSON REUTERS
·
13 Jan

Natera Q4 Revenue USD 472 Million

THOMSON REUTERS
·
13 Jan

Press Release: Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024

Dow Jones
·
13 Jan

Guardant Health Holds 'Underappreciated' Catalyst Path, UBS Says

MT Newswires Live
·
11 Jan

Natera Is Maintained at Outperform by Bernstein

Dow Jones
·
11 Jan

Natera price target raised to $200 from $160 at Bernstein

TIPRANKS
·
10 Jan